Geographic variations in the PARADIGM-HF heart failure trial
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
AIMS: The globalization of clinical trials has highlighted geographic variations in patient characteristics, event rates, and treatment effects. We investigated these further in PARADIGM-HF, the largest and most globally representative trial in heart failure (HF) to date. METHODS AND RESULTS: We looked at five regions: North America (NA) 602 (8%), Western Europe (WE) 1680 (20%), Central/Eastern Europe/Russia (CEER) 2762 (33%), Latin America (LA) 1433 (17%), and Asia-Pacific (AP) 1487 (18%). Notable differences included: WE patients (mean age 68 years) and NA (65 years) were older than AP (58 years) and LA (63 years) and had more coronary disease; NA and CEER patients had the worst signs, symptoms, and functional status. North American patients were the most likely to have a defibrillating-device (54 vs. 2% AP) and least likely prescribed a mineralocorticoid receptor antagonist (36 vs. 65% LA). Other evidence-based therapies were used most frequently in NA and WE. Rates of the primary composite outcome of cardiovascular (CV) death or HF hospitalization (per 100 patient-years) varied among regions: NA 13.6 (95% CI 11.7-15.7) WE 9.6 (8.6-10.6), CEER 12.3 (11.4-13.2), LA 11.2 (10.0-12.5), and AP 12.5 (11.3-13.8). After adjustment for prognostic variables, relative to NA, the risk of CV death was higher in LA and AP and the risk of HF hospitalization lower in WE. The benefit of sacubitril/valsartan was consistent across regions. CONCLUSION: There were many regional differences in PARADIGM-HF, including in age, symptoms, comorbidity, background therapy, and event-rates, although these did not modify the benefit of sacubitril/valsartan. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT01035255.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957 · cited 2×
“Safety outcomes included hypotension, elevation of serum creatinine, hyperkalaemia, cough, and angioedema, as previously reported.(18) We also reported total number of adverse, and serious adverse events according to geographic region.”
Self-citationGlobal epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Cited by
Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
Dokainish, H., Teo, K., Zhu, J., Roy, A., AlHabib, K. F., ElSayed, A., Palileo-Villaneuva, L., Lopez-Jaramillo, P., Karaye, K., Yusoff, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30196-1 · Cited by 409
Self-citationWachter, R., Senni, M., Belohlavek, J., Straburzynska-Migaj, E., Witte, K. K., Kobalava, Z., Fonseca, C., Goncalvesova, E., Cavusoglu, Y., Fernandez, A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1498 · Cited by 354
Self-citationJohansson, I., Joseph, P., Balasubramanian, K., McMurray, J. J. V., Lund, L. H., Ezekowitz, J. A., Kamath, D., Alhabib, K., Bayes-Genis, A., Budaj, A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050850 · Cited by 307
Self-citationMartinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044133 · Cited by 210
Self-citation
Metadata
- Authors
- Kristensen, S. L., Martinez, F., Jhund, P. S., Arango, J. L., Bĕlohlávek, J., Boytsov, S., Cabrera, W., Gomez, E., Hagège, A. A., Huang, J., Kiatchoosakun, S., Kim, K.-S., Mendoza, I., Senni, M., Squire, I. B., Vinereanu, D., Wong, R. C.-C., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., & McMurray, J. J. V.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-28
- Volume
- 37
- Issue
- 41
- Pages
- 3167-3174
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2474196988
- Cited by
- 139
- References
- 2
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Geographic variations in the PARADIGM-HF heart failure trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehw226
- The paper
- Kristensen, S. L., Martinez, F., Jhund, P. S., Arango, J. L., Bĕlohlávek, J., Boytsov, S., Cabrera, W., Gomez, E., Hagège, A. A., Huang, J., Kiatchoosakun, S., Kim, K.-S., Mendoza, I., Senni, M., Squire, I. B., Vinereanu, D., Wong, R. C.-C., Gong, J., Lefkowitz, M. P., . . . McMurray, J. J. V. (2016). Geographic variations in the PARADIGM-HF heart failure trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.